The Risk of Hemorrhage and Nursing Care in Patients with Crimean-Congo Hemorrhagic Fever/ Kırım-Kongo Kanamalı Ateşi Tanılı Hastalarda Kanama Riski ve Hemşirelik Bakımı
Öz
Thrombocytopenia is seen at a rate of 95-100% in patients diagnosed with Crimean-Congo Hemorrhagic Fever (CCHF). Activation of the coagulation cascade with the effect of endothelial damage leads to thrombocytopenia, hemorrhage, disseminated intravascular coagulation, and multi-organ failure. The presence of poor prognosis factors causes the thrombocytopenia to rapidly deepen, and insufficient transfusion causes increased mortality rates. In patients with CCHF, independent nursing interventions include identification of hemorrhage/hemorrhage risk, determining the factors causing hemorrhage, and solving the hemorrhage risk problem. Hence, the nurses who work in the unit where CCHF patients are treated should identify the hemorrhage risk in detail, specify individualized nursing interventions, follow evidence-based practice and be in collaboration with other health staff. This review presents information about nursing care aiming at hemorrhage/ hemorrhage risk developing from thrombocytopenia in patients with CCHF.
Keywords: Crimean-Congo Hemorrhagic Fever; Hemorrhage; Nursing Care; Thrombocytopenia.
Anahtar Kelimeler
Kaynakça
- 1. Crimean-Congo haemorrhagic fever [WHO website]. January 2013. Available at: https://www.who.int/news-room/factsheets/detail/crimean-congo-haemorrhagic-fever. Accessed February 27, 2021.
- 2. Introduction to Crimean-Congo Haemorrhagic Fever [WHO website]. December 2019. Available at: https://www.who.int/publications/i/item/introduction-to-crimean-congo-haemorrhaigc-fever. Accessed February 27, 2021.
- 3. Mertens M, Schmidt K, Ozkul A, Groschup, MH. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral research. 2013; 98(2): 248-260. https://doi.org/10.1016/j.antiviral.2013.02.007
- 4. Ince Y, Yasa C, Metin M, Sonmez M, Meram E, Benkli B, et al. Crimean-Congo hemorrhagic fever infections reported by ProMED. International Journal of Infectious Diseases. 2014; 26: 44-46. https://doi.org/10.1016/j.ijid.2014.04.005
- 5. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. International Journal of Infectious Diseases. 2009; 13(3): 380-386. https://doi.org/10.1016/ j.ijid.2008.07.021
- 6. Sheikh AS, Sheikh AA, Sheikh NS, Asif M, Afridi F, Malik MT. Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience. International Journal of Infectious Diseases. 2005; 9(1): 37-42. https://doi.org/ 10.1016/j.ijid.2004.02.007
- 7. Bakir, M., Ugurlu, M., Dokuzoguz, B., Bodur, H., Tasyaran, M. A., Vahaboglu, H., et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. Journal of medical microbiology. 2005; 54(4): 385-389. https://doi.org/10.1099/jmm.0.45865-0
- 8. Spengler JR, Bergeron É, Spiropoulou CF. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Current opinion in virology. 2019; 34: 70-78. https://doi.org/10.1016/j.coviro.2018.12.002
Ayrıntılar
Birincil Dil
İngilizce
Konular
Hemşirelik
Bölüm
Derleme
Yazarlar
Yayımlanma Tarihi
31 Ocak 2022
Gönderilme Tarihi
18 Ocak 2022
Kabul Tarihi
28 Ocak 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 17 Sayı: 1
